Pain and Inflammation Research
Although separate conditions, pain and inflammation are nearly always associated with each other. Pain is defined by the International Association for the Study of Pain (IASP) as 'an unpleasant sensory and emotional experience associated with actual or potential tissue damage, or described in terms of such damage'. Inflammation is the tissue's immunologic response to injury, characterized by mobilization of white blood cells and antibodies, swelling, and fluid accumulation.
Pain and Inflammation Research Products Areas
Products for Pain and Inflammation Research - Page 68
- Cat.No. Product Name Information/Activity
-
BCC6572
Kainic acid
Kainic acid is a potent agonist at excitatory amino acid receptor subtypes in the CNS.
-
BCC7297
MNI caged kainic acid
1315378-75-6
-
BCC6840
SYM 2081
SYM 2081 is a high-affinity ligand and potent, selective agonist of kainate receptors, inhibits [3H]-kainate binding with an IC50 of 35 nM, almost 3000- and 200-fold selectivity for kainate receptors over AMPA and NMDA receptors respectively.
-
BCC7462
ACET
936095-50-0
-
BCC7275
NS 3763
70553-45-6
-
BCC7255
UBP 296
745055-86-1
-
BCC7172
UBP 301
569371-10-4
-
BCC7256
UBP 302
UBP 302 is a potent and selective GLUK5-subunit containing kainate receptor antagonist (apparent Kd=402 nM), and displays very little affinity on GluK2 (GluR6) kainate receptors. Anxiolytic effects.
-
BCC6052
UBP 310
902464-46-4
-
BCC5883
PDZ1 Domain inhibitor peptide
1315378-73-4


